NEW YORK, Jan. 26 (UPI) -- Drugmaker Pfizer announced Monday it had reached a $68 billion cash-and-stock agreement to merge with U.S. rival Wyeth.
NEW YORK, Jan. 23 (UPI) -- U.S. drug maker Pfizer Inc. is in talks with Wyeth about a possible purchase of the pharmaceutical rival, sources said.
MADISON, N.J., Jan. 25 (UPI) -- New Jersey-based drug maker Wyeth confirmed Friday it may cut its work force by about 10 percent over the next three years, a report said Friday.
FRANKFURT, Germany, Dec. 4 (UPI) -- Shares of Pfizer Inc., the New York drug giant, tumbled Monday in European trading after a key cholesterol medicine prospect was being halted.
SEOUL, April 19 (UPI) -- Pfizer Inc. is closing its Seoul pharmaceutical plant, a facility that makes the hypertension drug Norvasc.
LITTLE FALLS, N.J., Feb. 13 (UPI) -- The consumer business of big U.S. pharmaceutical Pfizer Inc. is worth between $10 billion to $15 billion, a consulting firm says.
NEW YORK, Aug. 12 (UPI) -- Pharmaceutical giant Pfizer Inc. said about half of its new U.S. ads would encompass awareness of diseases and public health issues.
MADISON, N.J., Jan. 10 (UPI) -- U.S. pharmaceutical company Wyeth agreed to revise a class-action settlement of pending diet-drug claims, the Wall Street Journal said Monday.
ST. PAUL, Minn., March 3 (UPI) -- Minnesota's State Board of Pharmacy Wednesday adopted a resolution pushing pharmaceutical giant Pfizer to restructure its prescription drug pricing.
NEW YORK, June 27 (UPI) -- Pfizer Inc., the world's largest drug maker, says its scientists are making progress against infectious scourges such as malaria, smallpox and SARS.
